P0886 : Efficacy and safety of grazoprevir/elbasvir +/- RBV...

Journal of Hepatology 2015 / 04 Vol. 62

P0886 : Efficacy and safety of grazoprevir/elbasvir +/- RBV for 12 weeks in patients with HCV G1 or G4 infection who previously failed peginterferon/RBV: C-edge treatment-experienced trial

Kwo, P., Gane, E., Peng, C.-Y., Pearlman, B., Vireling, J., Serfaty, L., Buti, M., Shafran, S., Stryszak, P., Lin, L., Gress, J., Robertson, M., Wahl, J., Barr, E., Haber, B.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
62
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(15)31088-6
Date:
April, 2015
File:
PDF, 111 KB
english, 2015
Conversion to is in progress
Conversion to is failed